Joliet, IL 的 肺癌 臨床試驗
12 項針對 肺癌 的研究正在 Joliet(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 距離 6 英里
- University of Chicago Medicine-Orland Park, Orland Park · 距離 14 英里
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
招募中3 期
- Northwestern Medicine Orland Park, Orland Park · 距離 14 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Northwestern Medicine Orland Park, Orland Park · 距離 14 英里
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
招募中2 期
- Hope and Healing Clinical Research, New Lenox · 距離 6 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Hope and Healing Cancer Services, New Lenox · 距離 6 英里
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Hope and Healing Cancer Services, New Lenox · 距離 6 英里
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
招募中2 期
- Hope and Healing Clinical Research, New Lenox · 距離 6 英里
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
招募中1/2 期
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 距離 6 英里
- University of Chicago Medicine-Orland Park, Orland Park · 距離 14 英里
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- University of Chicago, New Lenox · 距離 6 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Orland Park, Orland Park · 距離 14 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Northwestern Medicine Orland Park, Orland Park · 距離 14 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Orland Park, Orland Park · 距離 14 英里
其他城市的 肺癌 試驗
- Houston, TX78 項研究
- Boston, MA62 項研究
- New York City, NY60 項研究
- Los Angeles, CA45 項研究
- Arlington, VA41 項研究
- Washington, DC41 項研究
- Chicago, IL41 項研究
- Nashville, TN40 項研究
- Baltimore, MD40 項研究
- St. Louis, MO39 項研究
- Columbus, OH37 項研究
- Philadelphia, PA36 項研究
Joliet 的其他研究
- 非小細胞肺癌12 項研究
- 膀胱癌7 項研究
- 轉移性癌症7 項研究
- 頭頸部鱗狀細胞癌6 項研究
- 前列腺癌5 項研究
- 急性髓系白血病5 項研究
- 下咽癌5 項研究
- 喉癌5 項研究
- 口腔癌5 項研究
- 乳癌4 項研究
- 卵巢癌4 項研究
- 結腸癌4 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。